Tanespimycin
- Generic Name
- Tanespimycin
- Drug Type
- Small Molecule
- Chemical Formula
- C31H43N3O8
- CAS Number
- 75747-14-7
- Unique Ingredient Identifier
- 4GY0AVT3L4
Overview
Tanespimycin, manufactured by Conforma Therapeutics is under development as a small molecule inhibitor of heat shock protein 90 (HSP90). It is developed for the treatment of several types of cancer, solid tumors or chronic myelogenous leukemia.
Background
Tanespimycin, manufactured by Conforma Therapeutics is under development as a small molecule inhibitor of heat shock protein 90 (HSP90). It is developed for the treatment of several types of cancer, solid tumors or chronic myelogenous leukemia.
Indication
Investigated for use/treatment in leukemia (myeloid) and solid tumors.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath